Showing results (2781-2790 of 11,104) with videos related to
Sort By:
Pageof 1,111
Journal of the National Cancer Institute|September 17, 2026
Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysisCody Z Watling, Jessica L Petrick, Barry I Graubard, et al.Journal of the National Cancer Institute|September 30, 2026
Trends in U.S. breast cancer mortality by estrogen receptor statusJacqueline B Vo, Paloma R Mitra, Macy E Corley, et al.Journal of the National Cancer Institute|September 30, 2026
Two-to-one randomization is associated with increased control-arm patient withdrawalBoris Freidlin, Edward L KornJournal of the National Cancer Institute|October 5, 2026
Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019Adino Tesfahun Tsegaye, Aimée R Kreimer, Jaimie Z Shing, et al.Journal of the National Cancer Institute|October 2, 2026
Obesity and survival of Asian American and White women with breast cancerEsther M John, Marilyn L Kwan, Jocelyn Koo, et al.Journal of the National Cancer Institute|October 22, 2026
Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop reportAsif Rizwan, Hala R Makhlouf, Ana I Robles, et al.Journal of the National Cancer Institute|October 20, 2026
Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling studyRosita van den Puttelaar, Kewei Sylvia Shi, Jingxuan Zhao, et al.Journal of the National Cancer Institute|October 24, 2026
Employment after curative breast cancer treatment: the breast cancer and the workforce cohort studyVictoria S Blinder, Yashasvini Sampathkumar, Sujata Patil, et al.Journal of the National Cancer Institute|October 24, 2026
Modeling the survival impact of the Inflation Reduction Act out-of-pocket cap in multiple myelomaHan Zhao, Stanley Teng, Cynthia Dong, et al.Journal of the National Cancer Institute|October 24, 2026
A clinical model incorporating early lymphocyte dynamics in HER2-positive breast cancerColin P Bergstrom, Ingrid Luo, Gregory R Bean, et al.Pageof 1,111